RBC Capital Downgrades Adverum Biotech to Sector Perform, PT to $4.

Thursday, May 15, 2025 12:03 pm ET1min read

RBC Capital Downgrades Adverum Biotech to Sector Perform, PT to $4.

Comments



Add a public comment...
No comments

No comments yet